Category:
Endocrine and Metabolic Preparations
CAS NO:
-
Standard:
USP,
Metformin hydrochloride sustained-release tablets belong to the biguanide class of hypoglycemic drugs, which can reduce liver glucose production and intestinal glucose absorption, and reduce basal and postprandial blood glucose by increasing peripheral glucose uptake and utilization and improving insulin sensitivity.This drug is preferred for type 2 diabetes patients who are unable to control blood glucose by diet and physical exercise alone, especially those with obesity and hyperinsulinemia. It can be used alone or in combination with sulfonylureas or insulin.
Specification: 500mg